Core Insights - Investors in the Medical - Drugs sector may find value in USANA Health Sciences (USNA) and Stevanato Group (STVN), with a need for closer examination to determine which stock offers better value [1] Valuation Metrics - USNA has a forward P/E ratio of 11.11, while STVN has a significantly higher forward P/E of 35.68 [5] - The PEG ratio for USNA is 0.93, indicating a more favorable valuation compared to STVN's PEG ratio of 7.24 [5] - USNA's P/B ratio stands at 1.23, contrasting with STVN's P/B ratio of 5.04, suggesting USNA is more undervalued relative to its book value [6] Earnings Outlook - USNA currently holds a Zacks Rank of 1 (Strong Buy), indicating positive earnings estimate revisions, while STVN has a Zacks Rank of 4 (Sell) [3] - The stronger estimate revision activity for USNA suggests a more favorable earnings outlook compared to STVN [7] Value Grades - Based on various valuation metrics, USNA has been assigned a Value grade of A, whereas STVN has a Value grade of D, indicating USNA is perceived as a better investment opportunity [6]

Core Insights - The article emphasizes the importance of value investing and highlights USANA Health Sciences (USNA) as a strong value stock opportunity based on its current metrics and Zacks Rank [2][3][7] Company Metrics - USNA has a Zacks Rank of 1 (Strong Buy) and an A for Value, indicating it is among the best value stocks available [3] - The PEG ratio for USNA is 0.92, significantly lower than the industry average of 2.06, suggesting it is undervalued relative to its expected earnings growth [4] - USNA's P/B ratio is 1.23, which is attractive compared to the industry's average P/B of 1.29, indicating a favorable market value to book value comparison [5] - The P/CF ratio for USNA stands at 8.68, which is also appealing when compared to the industry's average P/CF of 8.90, reflecting a strong cash flow outlook [6] - Over the past year, USNA's P/CF has fluctuated between 8.43 and 11.97, with a median of 10.33, further supporting its valuation attractiveness [6] Industry Context - The average PEG ratio in USNA's industry is 2.06, indicating that USNA is positioned favorably against its peers in terms of growth expectations [4] - The industry average P/B ratio is 1.29, which places USNA's P/B ratio of 1.23 in a competitive light [5] - The industry average P/CF ratio is 8.90, making USNA's P/CF of 8.68 relatively appealing [6]

Dr. Kathryn Armstrong brings 17 years of scientific expertise to the companySALT LAKE CITY, Jan. 22, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company. Kathryn has served as USANA's executive vice president of research and development since July of 2024.  Kathryn's predecessor, Dr. Rob Sinnott, announced his retirement at the end of 2024, but wil ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.In addition to t ...

Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and UCB SA (UCBJY) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with p ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they beli ...

SALT LAKE CITY, Nov. 12, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, was recently awarded Manufacturer of the Year for the third consecutive year by the Utah Manufacturers Association in the "mega-sized (500+ employees) companies" category.To learn more about USANA and its commitment to quality, please visit USANA.com.   USANA Named Top Manufacturer in Utah for Third Time "Our manufacturing capabilities are one of our biggest differentiators as a company," said Jim ...

Company Overview - USANA Health Sciences is a global leader in health and wellness products, founded in 1992, and operates in 25 countries [8] - The company emphasizes the importance of social wellness in building a successful business and focuses on clear communication to build trust with customers and distributors [8] National Gratitude Month - USANA encourages the celebration of National Gratitude Month, highlighting the positive impact of gratitude on health and happiness [1][2] - The company promotes the idea that gratitude can enhance psychological well-being and boost physical health [1] Research Findings - Studies indicate that grateful individuals experience better sleep, reduced stress, healthier diets, and increased physical activity [3] - A Harvard study from July 2024 found a connection between gratitude and longevity among older adults [3] Key Principles of Gratitude - Kevin Guest, CEO of USANA, emphasizes core values such as faith, family, service, gratitude, and honesty [4] - Guest suggests three practices to enhance feelings of gratitude: maintaining a Gratitude Jar, sending thank-you notes, and performing random acts of kindness [5] Personal Reflections - Guest expresses personal gratitude towards his family, particularly his parents and wife, highlighting the influence they have had on his life [6][7] - The book "All the Right Reasons" by Guest shares inspiring examples of gratitude, with proceeds going to feed hungry children, providing 40 meals for each book purchased [7]

Financial Data and Key Metrics Changes - Third quarter net sales fell modestly short of internal expectations, with a decline of 4% in the China market despite a 7% increase in active customer counts year-over-year [5][6] - The company anticipates a continued challenging operating environment through the remainder of the year and plans to increase promotional activity in the fourth quarter [5][6] Business Line Data and Key Metrics Changes - The company launched new products, including the Celavive Resurfacing Serum and a Whey Protein Isolate, under a new commercial team structure, indicating a focus on product innovation [7][8] - The product development process has been restructured to enhance speed and efficiency, with a robust pipeline of new products planned for 2025 [10][11] Market Data and Key Metrics Changes - The operating environment in key markets, particularly China, has been challenging, impacting sales performance [5][6] - Active customer acquisition has been greater than in 2023, with an increase in active customer counts noted [23][24] Company Strategy and Development Direction - The company continues to focus on engaging with associate sales leaders and enhancing product offerings to drive long-term customer and revenue growth [6][7] - There is an emphasis on ensuring existing product lines remain competitive while introducing new products across various categories [13][14] Management Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding government stimulus measures in China, indicating potential positive impacts on consumer sentiment and spending in the future [23][24] - The company is committed to investing in organic business growth and exploring business development opportunities while considering share repurchase options when appropriate [22] Other Important Information - The company is adjusting its promotional activities, which may affect both associate incentive expenses and gross margins [17][18] - The new whey protein product is not specifically designed for customers on GLP-1 drugs but is positioned as a premium offering [20] Q&A Session Summary Question: Feedback from the Las Vegas Convention - Positive feedback was received from the convention, indicating that sales leaders feel the company is moving in the right direction and are excited for the future [9] Question: New Product Development Process - The faster product development process is attributed to internal restructuring and improved collaboration among teams, with no immediate need for additional hires [10][12] Question: Impact of Reduced Advertising on Sales - Reduced advertising was part of a strategy to move away from ineffective activities, and the company is looking to repurpose funds to stimulate sales [15] Question: Promotional Activity Impact on Expenses - Increased promotional activity is expected to affect both associate incentives and gross margins, with a focus on driving new customer engagement [17][18] Question: Capital Allocation and Cash Management - The company is focused on investing in organic growth and exploring business development opportunities, with share repurchase considered when excess cash is available [22] Question: Government Stimulus in China - Management is cautiously optimistic about government stimulus measures in China, believing they may positively influence consumer sentiment over time [23][24]

USANA Health Sciences (USNA) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this nutritional supplement maker would post earnings of $0.65 per share when it actually produced earnings of $0.54, delivering a surprise of -16.92%.Over the last ...